Fresh Tracks Therapeutics Email Format

Pharmaceutical ManufacturingColorado, United States2-10 Employees

The company is a clinical-stage pharmaceutical organization based in Boulder, Colorado, focused on developing therapies for autoimmune, inflammatory, and other debilitating diseases. It aims to deliver differentiated prescription therapeutics by drawing on a leadership team with extensive experience across early research through global commercialization. The leadership has held senior roles at large pharmaceutical and biotech companies that have developed or launched first-in-class medicines, including Cialis, Taltz, Gemzar, Prozac, Cymbalta, Juvederm, Pluvicto, and Sofpironium Bromide.

In recent years the company has undergone notable corporate developments, including changes in governance and management, and actions related to market listings. It has disclosed preclinical data on a potential first-in-class DYRK1A inhibitor, FRTX-02, and established a Scientific Advisory Board to guide its research. The company’s public presence is maintained through frtx.com.

Get verified Fresh Tracks Therapeutics emails free

Company overview Employee directory